Bobrow J C
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO, USA.
Am J Ophthalmol. 2000 Mar;129(3):291-6. doi: 10.1016/s0002-9394(99)00342-6.
To determine whether extracapsular cataract extraction and posterior chamber lens implantation combined with trabeculectomy provides better long-term results than extracapsular cataract extraction and lens implantation alone in a group of patients with primary open-angle glaucoma and cataract.
In a prospective, randomized clinical trial, 35 patients with bilateral, symmetric, primary open-angle glaucoma and visually disabling cataracts were randomly selected to undergo surgery with trabeculectomy in one eye and without in the other. All procedures were performed by a single surgeon in a private practice setting with follow-up for more than 5 years in all cases.
After an average of 87 months of follow-up, extracapsular cataract extraction and posterior chamber lens implantation reduced intraocular pressure by 4.4 +/- 3.3 mm Hg, reduced the number of medications by 1.28 +/- 0.86, increased diopter vector of astigmatism by 1.49, and was associated with visual field loss in six of 35 eyes. After an average of 80 months of follow-up, extracapsular cataract extraction and posterior chamber lens implantation with trabeculectomy reduced intraocular pressure by 8.2 +/- 4.6 mm Hg (P =.0001), reduced the number of medications by 1.76 +/- 0.82 (P=.0002), increased diopter vector of astigmatism by 1.14, and was associated with visual field loss in one eye (P =.05). Both groups had similar improvement in visual acuity and perioperative complications.
Extracapsular cataract extraction and posterior chamber lens implantation with trabeculectomy was beneficial in the long-term control of intraocular pressure and in prevention of visual field loss. This procedure should be considered for patients in whom long-term pressure control at a lower level would be beneficial in preventing further optic nerve damage.
确定在一组原发性开角型青光眼合并白内障患者中,囊外白内障摘除联合后房型人工晶状体植入术与小梁切除术相结合,是否比单纯囊外白内障摘除和人工晶状体植入术能带来更好的长期效果。
在一项前瞻性随机临床试验中,35例双侧对称性原发性开角型青光眼且伴有视力障碍性白内障的患者被随机选取,一只眼行小梁切除术,另一只眼不行小梁切除术。所有手术均由一名私人执业医生进行,所有病例均随访超过5年。
平均随访87个月后,囊外白内障摘除联合后房型人工晶状体植入术使眼压降低4.4±3.3mmHg,药物使用数量减少1.28±0.86,散光屈光度向量增加1.49,35只眼中有6只眼出现视野缺损。平均随访80个月后,囊外白内障摘除联合后房型人工晶状体植入术并小梁切除术使眼压降低8.2±4.6mmHg(P = 0.0001),药物使用数量减少1.76±0.82(P = 0.0002),散光屈光度向量增加1.14,仅1只眼出现视野缺损(P = 0.05)。两组在视力改善和围手术期并发症方面相似。
囊外白内障摘除联合后房型人工晶状体植入术并小梁切除术在长期控制眼压和预防视野缺损方面有益。对于那些长期维持较低眼压水平有助于预防进一步视神经损伤的患者,应考虑采用该手术。